Neuro-pharmacological Study of Ketoconazole for High-grade Gliomas
Status:
Not yet recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
This research is being done to find out if the study drug (ketoconazole) can enter brain
tumors at a high enough amount to stop the tumor cells from dividing. Ketoconazole is a drug
which doctors already use for fungal infections and is thought to be able to effect tumor
cells. As treatments for this type of brain tumor are limited, it is hoped that the results
of this study will help to determine if the study drug should be studied further as a
possible treatment.